COMMUNIQUÉS West-GlobeNewswire

Full-year 2023 results
28/02/2024
Ludwig de Mot appointed Chief Executive Officer Strategic Review outcome: launch of the FOCUS-27 project to improve competitiveness and unlock sustainable & profitable growth Full-Year 2023 results: resilience in a [...]
Résultats annuels 2023
28/02/2024
Ludwig de Mot est nommé Directeur général Résultats de la revue stratégique : lancement du projet FOCUS-27 pour améliorer la compétitivité et libérer une croissance durable et rentable Résultats annuels 2023 : [...]
Vision Sensing Acquisition Corp. Announces Intention to Extend Period to Consummate Initial Business Combination to April 3, 2024
28/02/2024
MIAMI, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “Company”) a special purpose acquisition company, announced today that it has notified Continental Stock [...]
SAFE - CHIFFRE D’AFFAIRES 2023
28/02/2024
CHIFFRE D’AFFAIRES 2023 Eragny-sur-Oise - France - le 28 février 2024 à 18h . Safe SA (la « Société ») publie son chiffre d’affaires annuel consolidé réalisé sur l’exercice 2023. En k€ 2023* 2022 Variation en % Chiffre [...]
SAFE - MISE A DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL AU 30 JUIN 2023
28/02/2024
Eragny-sur-Oise - France - le 28 février 2024 à 18h . Safe SA (la « Société ») annonce la publication aujourd’hui de son rapport financier semestriel 2023 et son dépôt auprès de l’Autorité des marchés [...]
RAMSAY SANTE : Half-year results at end of December 2023
28/02/2024
PRESS RELEASE Paris, 28 February 2024 Half-year results at the end of December 2023 As a mission-driven company, Ramsay Santé continues its support for the care of all patients and all pathologies, both in France and in [...]
RAMSAY SANTE : résultats semestriels à fin décembre 2023
28/02/2024
COMMUNIQUÉ DE PRESSE Paris, le 28 février 2024 Résultats semestriels à fin décembre 2023 Entreprise à mission, Ramsay Santé poursuit son soutien pour la prise en charge de tous les patients, et toutes les pathologies, [...]
BioCorRx Pharmaceuticals Inc. Awarded NIDA Grant of Approximately $11 million Over Three Years for Research on BICX104, a Naltrexone Implant in Combination with Bupropion for the Treatment of MUD
28/02/2024
ANAHEIM, CA, Feb. 28, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of innovative treatment programs for substance use and related disorders, [...]
PickleJar Announces Sponsorship With CRS 2024 Including Multiple Activations
28/02/2024
PickleJar Up All Night Show to Broadcast Live; Hosted Backstage Interviews at New Faces of Country® Music NASHVILLE, TN, Feb. 28, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – PickleJar, PickleJar Entertainment Group (OTC [...]
Time to invest in team-based care and the training for health professionals who provide it: Team Primary Care Summit
28/02/2024
Health professionals, educators, and organizational leaders issue Call to Action to encourage governments to help Canada’s health care system Team Primary Care leaders discuss the importance of training for successful [...]
Il est temps d'investir dans les soins en équipe et dans la formation des professionnels de la santé qui les dispensent : Sommet d’Équipe de soins primaires
28/02/2024
Des professionnels de la santé, des éducateurs et des dirigeants d'organisations lancent un Appel à l'action pour inciter les gouvernements prêter main-forte au système de santé canadien Les responsables d’Équipe de [...]
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
28/02/2024
Please see enclosed pdf. Attachment 28022024_trading_in_shares_GL
Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office
28/02/2024
New patent strengthens Adial’s patent portfolio and covers AD04’s unique ability to target the serotonin transporter gene for the potential treatment of opioid use disorder CHARLOTTESVILLE, Va., Feb. 28, 2024 (GLOBE [...]
Virios Therapeutics Issues Shareholder Letter Highlighting Corporate Progress and Key Upcoming Milestones
28/02/2024
ATLANTA, Ga., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating [...]
Cassava Sciences Reports Full-year 2023 Financial Results and Corporate Updates
28/02/2024
$121.1 Million In Cash and Cash Equivalents at December 31, 2023, With an Additional $21.8 Million Raised In 2024 From Exercise of Warrants. A Total of Over 555 Study Participants Have Completed Our Phase 3 Studies. [...]
Ibogaine By David Dardashti is Offering Women Employment Opportunities
28/02/2024
Ibogaine By David Dardashti Research Team Empowers Women to Help Make a Difference MIAMI, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Our clinic Ibogaine By David Dardashti has made it a mission to help those who are struggling [...]
Femasys’ FemaSeed FDA Clearance Brings Timely Access to a First-Line Infertility Treatment Option as an Alternative to IVF
28/02/2024
-- Femasys readies for the commercial launch of FemaSeed ® in the U.S. amidst the uncertainty following the Alabama Supreme Court Ruling on how to handle embryos used for in vitro fertilization (IVF) -- -- Femasys to [...]
Scilex Holding Company Announces Major Initiative with a Leading National Pharmacy Chain to Stock GLOPERBA® in Most of Their Stores Throughout the U.S.
28/02/2024
Leading national pharmacy chain to stock GLOPERBA ® in majority of their stores throughout the U.S. Scilex is also in the process of negotiating similar potential stocking arrangements with additional pharmacy chains in [...]
LiveCare Inc.(OTCMKTS: LVCE) Enters Hypertension Market, Enhancing Healthcare Monitoring for U.S. Adults
28/02/2024
Venice, FL, USA, Feb. 28, 2024 (GLOBE NEWSWIRE) -- LiveCare Inc. (OTCMKTS: LVCE), a leading innovator in healthcare solutions, proudly announces the launch of a state-of-the-art blood pressure cuff device. This device [...]

Pages